Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., ...

The technological innovation is an expansion of the NOBIVAC NXT platform, and a breakthrough achievement against one of the ...

Merck Animal Health, a division of Merck & Co., Inc. (MRK), Tuesday announced the expansion of Nobivac NXT vaccine platform with the ...

Canine influenza - often referred to as dog flu - is a highly contagious respiratory disease that affects dogs. Unlike the ...

The man charged with attempting to assassinate Donald Trump after allegedly positioning himself with a rifle outside one of the former president's Florida golf courses on Sept. 15 pleaded not ...

Rachel Allbaugh, DVM, MS, DACVO, explains her squamous cell carcinoma diagnosis procedure, beyond just the clinical signs ...

RAHWAY, N.J. - Merck Animal Health, a division of Merck & Co., Inc. (NYSE:MRK), has announced the release of a new vaccine, NOBIVAC NXT FeLV, to protect cats against feline leukemia virus (FeLV). The ...

Sep. 9, 2024 — Researchers have developed a robotic leg with artificial muscles. Inspired by living creatures, it jumps across different terrains in an agile and ...

(RTTNews) - Merck Animal Health, a division of Merck & Co., Inc. (MRK), Tuesday announced the expansion of Nobivac NXT vaccine platform with the RNA-particle technology vaccine for the treatment ...

NOBIVAC NXT FeLV is the first and only feline leukemia virus vaccine built on Merck Animal Health’s RNA-particle technology platform and is designed to deliver optimized protection. The same ...

RAHWAY, N.J. - Merck Animal Health, a division of Merck & Co., Inc. (NYSE:MRK), has announced the release of a new vaccine, NOBIVAC NXT FeLV, to protect cats against feline leukemia virus (FeLV).

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the expansion of the newly ...